Ergoteles’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,300	Closed	-$262K	–	625
2023 Q2	$262K	Buy	+18,300	New	+$262K	0.01%	800
2022 Q4	–	Sell	-14,378	Closed	-$159K	–	1781
2022 Q3	$159K	Buy	+14,378	New	+$159K	0.01%	1259